In our previous study on gene expression analysis of ESCC, we also observed a 7-fold upregulation of LUM. Based on the above findings, we hypothesize that lumican could also be a potential biomarker if it could be detected in ESCC patient’s sera. The gene discussed is LUM; the disease is esophageal squamous cell carcinoma.